Pfizer More Than Doubles Price of Lifesaving Covid-19 Medication Paxlovid

The price of the lifesaving Covid-19 antiviral medication Paxlovid will more than double as the U.S. transitions out of the emergency phase of the pandemic, drugmaker Pfizer said last week.

The list price, before insurance, will be $1,390 for a five-day course, Pfizer said in a statement. That’s 2.6 times higher than the $530-per-course price paid by the U.S. government, which provided Paxlovid free to patients during the pandemic. Covid-19 vaccines also increased in price as they went through a similar transition to a commercial market, rising about fourfold to between $115 to $130 per dose. Read more from CNN here.